Categories: News

Truyo, an IntraEdge company, secures investment from Intel

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PHOENIX, Dec. 16, 2020 /PRNewswire/ — Truyo, an IntraEdge company and developers of the Truyo Privacy Platform and Health-Check Management Solutions, today announced a strategic investment from Intel that extends Truyo’s position as a leading innovator in the privacy technology market with the introduction of the California Privacy Rights Act and a new privacy enforcement body in 2021.   

The investment underscores the importance of automation and quality privacy user experience as the privacy landscape changes. 2020 saw further legislative change with the passing of the California Privacy Rights Act and mounting state-level legislation that if passed in 2021, would impact more than half the U.S. population’s data.

“If anything, privacy has become even more important during the pandemic,” said Kal Somani, CEO at IntraEdge. “Our investment partnership with Intel supports the continued development of Truyo’s offerings, offering better privacy experiences for users, consumers and employees. With our focused approach to privacy rights and consent management, organizations can stay on top of the latest regulations while bracing for continued uncertainty.”

With its Privacy Platform powered by Intel® SGX, Truyo specializes in global privacy compliance and creates better privacy experiences with an all-in-one approach to privacy rights and consent management. This investment will further enable Truyo to reduce the cost and eliminate the manual processes associated with subject access requests, consent and preference management in the changing privacy landscape.

“The need for automated privacy compliance technology is accelerating with the growth of cloud, distributed edge computing and AI,” said Stacey Shulman, Vice President, Internet of Things Group and GM, Health, Life Sciences and Emerging Technologies at Intel. “As organizations face increasing data privacy regulations, end-to-end privacy solutions will become more important. We’re excited to invest in the growing privacy compliance automation segment with innovators like Truyo.”

Additionally, the investment will further accelerate Truyo’s Health-Check Management Solutions innovation. Truyo’s expertise in privacy and compliance has paved the way for its comprehensive health and wellness solutions that include temperature checking hardware options such as Janus and QuikSense, and its standalone software offering of the Health-Check Management Solutions.

Truyo’s privacy-first approach to temperature and wellness checks enables employers with remote, in-office and decentralized and hybrid workforces the ability to monitor and manage employee health checks from one secure platform amid the changing workforce.

“As the pandemic continues to take hold in our daily lives, privacy needs to go hand-in-hand with public safety,” said Dan Clarke, President of Truyo. “Businesses are collecting more, and often highly-regulated health data and user privacy cannot be sacrificed. With Truyo’s solutions, health and privacy can both be protected.”

To learn more about Truyo, please visit, www.truyo.com.

About Truyo
Truyo, an IntraEdge company, powered by Intel®, offers customers true consent and data privacy rights management automation. Specializing in privacy UX, Truyo has a nuanced understanding and a depth of experience in operational delivery of privacy rights management creating better privacy rights and consent management experiences for users and companies. Through its Truyo Privacy Platform and Health-Check Management Solutions, Truyo enables global organizations to manage complex compliance requirements, minimize risk and deliver fast ROI.

 

View original content:http://www.prnewswire.com/news-releases/truyo-an-intraedge-company-secures-investment-from-intel-301193779.html

SOURCE Truyo

Staff

Recent Posts

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…

18 hours ago

Saudi Arabia Concludes Landmark BIO 2025 Debut as Kingdom Opens Doors to Global Biotech Collaboration

From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…

18 hours ago

Enzon and Viskase Enter into Merger Agreement

Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…

18 hours ago

Novo Nordisk’s subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025

Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…

18 hours ago